Price$64.73+0.08 (+0.12%)
01:30 PM01:45 PM
News · 26 weeks98-73%
2025-12-142026-06-07
Mix5090d
- Insider19(38%)
- Other20(40%)
- SEC Filings6(12%)
- Earnings2(4%)
- Analyst2(4%)
- Leadership1(2%)
Latest news
25 items- PRGE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilitiesMarking the evolution of MIM AI-enabled auto-contouring software, MIM Contour ProtégéAI+ 2.0 introduces new models, including a Magnetic Resonance (MR) Brain model, as well as an updated Computed Tomography (CT) Male Pelvis model, expanding clinical capabilities across key anatomical regions. GE HealthCare will showcase MIM Contour ProtégéAI+ 2.0 at booth #202 during the American Association of Medical Dosimetrists 51st Annual Meeting taking place June 7-10, 2026 in Orlando, Florida. GE HealthCare (NASDAQ:GEHC) today announced it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for MIM Contour ProtégéAI+™ 2.0, an AI-enabled auto-contouring softw
- SECSEC Form SD filed by GE HealthCare Technologies Inc.SD - GE HealthCare Technologies Inc. (0001932393) (Filer)
- INSIDERDirector Lobo Kevin bought $641,800 worth of shares (10,000 units at $64.18), increasing direct ownership by 229% to 14,363 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- ANALYSTGE HealthCare upgraded by UBS with a new price targetUBS upgraded GE HealthCare from Sell to Neutral and set a new price target of $69.00
- INSIDERCEO, AIS Rackliffe Philip was granted 16,458 shares, increasing direct ownership by 62% to 43,187 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERCEO, Patient Care Solutions Bankes Jeannette covered exercise/tax liability with 5,535 shares, decreasing direct ownership by 13% to 38,357 units (SEC Form 4) (tax withholding)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- PRCardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial FrontsIssued on behalf of Ventripoint Diagnostics Ltd.A Toronto-based small-cap is converting clinical validation into real-world hospital deployments at the moment AI cardiac imaging procurement is reorganizing globallyNEW YORK, May 19, 2026 /CNW/ -- USA News Group News Commentary — Cardiology has become one of the proving grounds for medical artificial intelligence, and the procurement environment around it has shifted hard in the last twelve months. Hospital networks are no longer content to evaluate clinical accuracy in isolation; they want department-level economic proof before they sign deployment contracts. That shift is reshaping which AI imaging companies can convert pilot data into recur
- SECAmendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.SCHEDULE 13G/A - GE HealthCare Technologies Inc. (0001932393) (Subject)
- INSIDERDirector Hochman Rodney F bought $100,365 worth of shares (1,618 units at $62.03) (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- PRESTRO 2026 Congress: GE HealthCare to spotlight AI-enabled solutions to advance precision care across radiation therapy and image-guided interventionsThe company will showcase the latest iRT solution, MIM software innovations, and BK Medical technology – advancing speed, connectivity, and personalized medicine across the cancer care pathway. At the European Society for Radiotherapy and Oncology (ESTRO) 2026 Congress in Stockholm, GE HealthCare (NASDAQ:GEHC) will highlight a portfolio of AI-enabled solutions designed to support clinicians across radiation therapy, theranostics, and image-guided interventions. The company's presence underscores its focus on reducing workflow complexity, improving coordination across departments, and enabling more timely and personalized cancer care. According to the World Health Organization, cancer
- INSIDERDirector Yang Watkin Phoebe L. was granted 3,586 shares and bought $63,006 worth of shares (1,000 units at $63.01), increasing direct ownership by 50% to 13,702 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Culp H Lawrence Jr was granted 7,743 shares, increasing direct ownership by 61% to 20,442 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Hochman Rodney F was granted 6,275 shares, increasing direct ownership by 46% to 19,886 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Lesjak Catherine A was granted 3,586 shares, increasing direct ownership by 39% to 12,702 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Lobo Kevin was granted 3,586 shares, increasing direct ownership by 462% to 4,363 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Madden Anne T was granted 5,868 shares, increasing direct ownership by 43% to 19,479 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Stromberg William J was granted 3,586 shares, increasing direct ownership by 23% to 18,916 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- SECGE HealthCare Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events8-K - GE HealthCare Technologies Inc. (0001932393) (Filer)
- PRGE HealthCare next-gen SIGNA MR technology helps advance research discovery and translate innovation into clinical impactGE HealthCare to showcase next-gen technologies including helium-free 1.5T MR, advanced 3T scanner and state-of-the-art AI-powered workflow at ISMRM 2026 Advanced MR research tools help simplify collaboration and speed development, empowering researchers to push boundaries As the global magnetic resonance (MR) community convenes for the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE HealthCare (NASDAQ:GEHC) today announced advancements in research tools and MR systems that aim to accelerate discovery, strengthen collaboration across research programs, and turn innovation into meaningful clinical achievements. GE HealthCare continues to inve
- INSIDERDirector Culp H Lawrence Jr bought $5,000,076 worth of shares (80,805 units at $61.88) (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERDirector Stromberg William J bought $61,689 worth of shares (1,000 units at $61.69), increasing direct ownership by 7% to 15,330 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERNew insider Estrampes Catherine claimed ownership of 24,081 shares (SEC Form 3)3 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERChief Financial Officer Saccaro James bought $200,585 worth of shares (3,310 units at $60.60), increasing direct ownership by 4% to 87,471 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
- INSIDERGC & Corporate Secretary Jimenez Frank R bought $105,788 worth of shares (1,750 units at $60.45), increasing direct ownership by 2% to 93,932 units (SEC Form 4)4 - GE HealthCare Technologies Inc. (0001932393) (Issuer)
GEHC FAQ
6 questionsWhere does GEHC stock trade?
GE HealthCare Technologies Inc. (GEHC) is listed on NASDAQ.What sector and industry is GEHC in?
GE HealthCare Technologies Inc. operates in the Health Care sector, Medical Electronics industry.Does GEHC pay a dividend?
GEHC's most recent ex-dividend date was 2026-04-02 with a cash dividend of $0.04 per share. No future ex-date is on file yet.What are analysts saying about GEHC?
GE HealthCare Technologies Inc. has had 8 recent analyst actions on file. The most recent action was from UBS: Neutral on 2026-05-21.What companies are similar to GEHC?
Notable peers in the same industry include PHG (Koninklijke Philips N.V. NY Registry Shares), HOLX (Hologic Inc.), BFLY (Butterfly Network Inc.), NNOX (NANO-X IMAGING LTD), CHEK (Check-Cap Ltd.). Compare GEHC side-by-side with any of them on Quantisnow.How can I track GEHC on Quantisnow?
Quantisnow aggregates GE HealthCare Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow GEHC to receive live email and push alerts on every new disclosure.